Category Archives: Healthcare

Global and Major Regions Development Status of Hip Orthosis Market

Hip OrthosisThe Global Hip Orthosis Market Analysis & Forecast Report 2016-2021 is a professional and in-depth study on the current state of the Hip Orthosis Market. The report analysis the global market of Hip Orthosis by main manufactures and geographic regions. The report includes Hip Orthosis definitions, classifications, applications and industry chain structure, development trends, competitive landscape analysis, and key regions development and import/export status.

For main manufacturers, company profiles, product analysis, Shipment/sales, ASP, revenue and contact information are included. For industry chain, Hip Orthosistream raw materials and equipment and downstream demand analysis are also carried out.

Request for Sample Market Report @ http://www.aarkstore.com/sample/401253

Region and Country Coverage:
Europe; UK, France, Germany, Italy, Spain, Netherlands, Belgium, Switzerland, Austria, Portugal, Denmark, Finland, Norway, Sweden, Ireland, Russia, Turkey, Poland, Western Europe, Central and Eastern Europe
North America: USA, Canada
Asia Pacific: Japan, China, South Korea, Australia, New Zealand

Major players Coverage:
Corflex
Bauerfeind
RCAI Restorative Care of America
Ossur
DonJoy
Innovation Rehab

Key Issues Addressed
1. Competitive Landscape and Strategic Recommendations
2. The market forecast and growth areas for Hip Orthosis Market
3. Changing Market Trends and Emerging Opportunities
4. Historical shipment and revenue
5. Analysis key applications
6. Main manufacturers market share

Related Market Research Reports:

Blood Flow Measurement Devices Market – Global Forecast to 2021

Global Hip and Knee Orthopedic Surgical Robots Sales Market Report 2017

Global Hipot Testers Market Research Report 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

The extracorporeal membrane oxygenation machine market is poised to reach USD 305.3 million by 2021

ecmo-machineOn the basis of modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is expected to account for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period.

Request for Sample Market Report @http://www.aarkstore.com/sample/428493

Based on application, the respiratory segment is expected to account for the largest share of the market, in 2016. The large share of this segment is mainly attributed to factors such as rising incidence of respiratory failure, lung cancer, growing lung transplants, and increasing adoption of ECMO systems.

North America is expected to account for the largest share of the global market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the favorable reimbursement scenario, the rising incidence of lung cancer, and the presence of a large number of ECMO centers in the U.S.

The market witnesses high competitive intensity, as there are several big and small firms with similar product offerings. These companies adopt various strategies (approvals, product launches, agreements & partnerships, expansions, rebranding, acquisitions, website launches, product deployments, and market development) to increase their market shares and establish a stronger foothold in the global market.

Research Coverage:

This report studies the ECMO machine market based on modality, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies to strengthen their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the ECMO machine market. The report analyzes the market based on modality, application, and region.

• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the ECMO machine market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various Extracorporeal Membrane Oxygenation (ECMO) products across regions.

• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the ECMO machine market

Related Market Research Reports

Global Extracorporeal Shockwave Lithotripsy Systems Sales Market Report 2017

Global Extracorporeal Ventricular Assist Device Market Professional Survey Report 2017

Global Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Market Report 2016

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

B-Cell Non-Hodgkin Lymphoma Therapeutics under Development by Companies

SUMMARY

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Non-Hodgkin Lymphoma. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsights Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for B-Cell Non-Hodgkin Lymphoma. DelveInsights Report also assesses the B-Cell Non-Hodgkin Lymphoma therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Request for Sample Market Report @ http://www.aarkstore.com/sample/178867

Scope

The report provides competitivepipeline landscape of B-Cell Non-Hodgkin Lymphoma
The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
Coverage of the B-Cell Non-Hodgkin Lymphoma pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
The report reviews key players involved in the therapeutics development for B-Cell Non-Hodgkin Lymphoma and also provide company profiling
The report also gives the information of dormant and discontinued pipeline projects
Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages

Reasons to buy Market Report

Complete Pipeline intelligence and complete understanding over therapeutics development for B-Cell Non-Hodgkin Lymphoma
Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
Devise corrective measures for pipeline projects by understanding B-Cell Non-Hodgkin Lymphoma pipeline depth and focus of Indication therapeutics
Developing strategic initiatives to support your drug development activities.
Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Related Market Research Reports

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016

Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2015

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2015

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

United States Insulin Pump Market is likely to reach USD 4 Billion by the year end of 2022.

insulin-pumpMarket growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pumps is hampering the growth of this market.

Request for Sample Market Report @http://www.aarkstore.com/sample/425976

The research report titled “United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms for the forecasted period for Insulin Pump Market has been detailed in the report. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Pump Users and Market Analysis (2011 – 2022)
• United States Insulin Pump Preferred Brand – By Product
• United States Insulin Pump Market: Reimbursement & Regulation System
• United States Insulin Pump Market – Major Deal Types

Key Companies Covered in the Report are as follows:

• Insulet Corporation
• Medtronic
• Roche
• Animas Corporation

TABLE  OF  CONTENTS        

1. Executive Summary 

2. United States Diabetes Population (2011 – 2022): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes

3. United States Insulin Pump Market Analysis (2011– 2022)
3.1 Insulin Pump Users
3.1.1 Type 1 Diabetes Insulin Pump Users
3.1.2 Type 2 Diabetes Insulin Pump Users
3.2 Insulin Pump Market

4. Key Drivers and Inhibitors of the United States Insulin Pump Market
4.1 Market Drivers
4.2 Inhibitors

5. United States Insulin Pump Preferred Brand – By Product
5.1 Pediatric
5.2 Adult

Related Market Research Reports

United States X-Ray Safety Glasses Market Report 2017

United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Japan Biosimilar- Active Players In Quest of a Specialty & Niche BS space

biosimilarFilgrastim BS and Lantus BS Approval- Encouraging uptake and a lesson to fast track JP approval based on Ex-Japan data!
Remicade biosimilar NK A slow start does not pull back NK in starting PhIII for Herceptin BS in Japan

Active companies in Biosimilar Space: Local Japanese Generic Giants- Opening door for Biosimilars in Japan? – Will go for All or Niche in BS space???- Opportunities beyond 2020?

View Full Market Report @http://www.aarkstore.com/healthcare/191334/japan-biosimilar-active-players-in-quest-of-a-specialty-niche-bs-space

Encouraging Uptake of Filgrastim BS and Lantus BS in 2015 in Japan is indicative of Japan being a key important market after the EU for growth of Biosimilar players in the next five years. Less stringent regulatory environment vs. US for approval, increasing healthcare burden and strong foothold of the marketers have played key roles in this early uptake which is at par to one of the best generic small molecule penetration in Japan in a short time (Filgrastim BS-volume share~45% in two years, Lantus BS- ~9% in 2 months vs. Lipitor generics ~50% volume share).

Request for Sample Market Report @http://www.aarkstore.com/sample/191334http://www.aarkstore.com/sample/191334

In contrast, there is a very slow uptake of Remicade Biosimilar post one year launch (~1% volume share). Biosimilars remains to be the key weapon to curb increasing healthcare cost in Japan & there is a forward pressure on Chuikyo (Central social Insurance Medical Council) by Zaimu-sho (Ministry of Finance- Japan) to increase use of biosimilars. We see that Abenomics measures and government involvement in biosimilar use would lead to the same type of progress for complex mAb Biosimilars in the coming times in Japan

The launch of Sandoz EU approved dosage form of Filgrastim BS in Japan, and Lantus BS based mainly on foreign studies (only one PhIII study involved JP patients from the eight studies submitted for approval) along with Celltrion-NK Remicade biosimilar in 2014/2015 in the Japan pharma market demonstrated more flexibility for EU- Ex-Japan data by JP regulatory authorities for a biosimilar approval and a less stringent path vs. US for BS approval.

While analyzing the launched biosimilar penetration since 2009 launch in Japan (Growth hormone, Erythropoietin, G-CSF), use of the product in DPC hospitals, simple protein moiety and product reimbursement under high cost medical care benefit programme of NHI/JP government are the key JP specific factors which decide uptake timeline and penetration of each biosimilar in Japan.
Since the last five years, most of the companies have some alliance in place for biosimilars, with most of the Japanese companies undertaking pacts with South Korean companies to ride on their back of biosimilar mAb expertise. There is a trend of doing product specific alliance by most of the JP companies active in BS space and to go step by step on this high risk/high return opportunities. Overall, in the Japan market, each opportunity has a different competitive landscape for itself, and some companies are looking for niche opportunities in biosimilar space as per their specialty therapy area- like ophthalmology BS (Lucentis), Enzyme therapy BS (JCR)

In this report, we attempt to analyze trend/requirement of regulatory approval of biosimilars based on Ex-Japan clinical trial data, Factors responsible for each key launched biosimilar penetration (Made in Japan vs. Tested by Japan), and the future competitive landscape in the biosimilars space in Japan. We also attempt to analyze detail BS market of EPO, Filgrastim/Pegfilgrastim/ Insulin/Lantus apart from other key complex Mab Biosimilar opportunities and list out niche opportunities in biosimilar space in Japan. It details all major consolidation activities done by JP/Foreign companies in biosimilar space in the last five years and crisp summary on strategies of each key player (~21 JP local companies, multinational companies), their interest & focus for future collaboration in biosimilar space.

Related Market Research Reports

Japan Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022

Japan Contrast Agents Market Outlook to 2022

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Orthopedic Devices Market Trends and Strategies

orthopedic-devices-marketOrthopedic devices are used for restoring skeletal structure and joint movements in various fractures, abnormal growth of bones, soft tissue damage, trauma or other deformities. These devices are implanted by surgical procedures or can be externally attached through minimally invasive procedures. Orthopedic devices can be classified as joint implants, internal and external fixation devices.

Americas was the largest region in the orthopedic devices market in 2016, accounting for around 40% of the market share. Europe was the second largest region accounting for over 30% of the market share. Asia was the third largest region accounting for around 16% of the market share.

Request for Sample Report@http://www.aarkstore.com/sample/389047

Biodegradable implants are increasingly being used in trauma orthopedic surgeries. Biodegradable implants are used to replace a missing biological structure, support a damaged biological structure, and enhance the existing bone structure. Biodegradable products such as reabosorbable polymers composed of polyglycolic acid and poly lactic acid manufactured in the form of plates, screws, and pins are replacing traditional devices like plates and screws which are more expensive. Surgeons are preferring biodegradable implants to replace conventional implants, as biodegradable implants can be engineered to provide temporary support for bone fractures; can degrade at a rate matching new tissue formation; can eliminate the need for second surgery, are highly useful in fracture fixation in children; and result in less implant related infections. For instance, Stryker Corp. offers orthrobiologics such as bone repair biodegradable products that are used in bone regeneration and bone healing, soft tissue regeneration and muscle connection to bone.

Related Market Research Reports

Global Metal Orthopedic Nail Sales Market Report 2017

Global Orthopedic Braces & Support System Market Research Report 2017

Europe Orthopedic Surgical Instruments Package Market Report 2017

Gain a high level view of the trends shaping and driving NSCLC market

non-small-cell-lung-cancerSummary

Non-Small Cell Lung Cancer (NSCLC) – Current and Future Players, The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing NSCLC Market. The report identifies and analyses the key companies shaping and driving the global NSCLC market. The report provides insight into the competitive NSCLC landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GDs team of industry experts.

Request for Sample Report@http://www.aarkstore.com/sample/373884

Scope

– Investigation of current and future market competition for NSCLC
– Competitor assessment
– Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
– Strategic assessment of NSCLC sector through market impact analysis, future market scenario and company analysis

Reasons to buy Market Report

– Gain a high level view of the trends shaping and driving NSCLC market
– Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
– Create an effective counter-strategy to gain a competitive advantage against those currently in the market
– Whats the next big thing in the global NSCLC market landscape? Identify, understand and capitalize

Related Market Research Reports

Non-Small Cell Lung Cancer (NSCLC) – China Drug Forecast and Market Analysis to 2025

Global Non-Small Cell Lung Cancer Partnering 2010 to 2017

Non-Small Cell Lung Cancer (NSCLC) – Japan Drug Forecast and Market Analysis to 2025

%d bloggers like this: